Michael Joseph Driscoll
CIK: 0001912097
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Organogenesis Holdings Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 9, 2026ORGO
Organogenesis Holdings Inc.
Purchase(P)Direct10K shares at avg. $2.67$27K - Feb 18, 2026ORGO
Organogenesis Holdings Inc.
Award(A)Direct48.8K shares- - Mar 4, 2025ORGO
Organogenesis Holdings Inc.
Sale(S)Direct25K shares at avg. $5.10$128K - Feb 19, 2025ORGO
Organogenesis Holdings Inc.
Award(A)Direct49.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 9, 2026 | ORGO Organogenesis Holdings Inc. | Purchase(P) | 10,000 | $2.67 | $26,688 | Direct |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | Award(A) | 48,828 | - | $0 | Direct |
| Mar 4, 2025 | ORGO Organogenesis Holdings Inc. | Sale(S) | 25,000 | $5.10 | $127,535 | Direct |
| Feb 19, 2025 | ORGO Organogenesis Holdings Inc. | Award(A) | 49,575 | - | - | Direct |
1-4 of 4 transactions
About Driscoll Michael Joseph
Driscoll Michael Joseph (SEC CIK 0001912097) files insider reports with the SEC as Director of Organogenesis Holdings Inc. (ORGO).
Signal8 holds 4 ownership filings by Driscoll Michael Joseph, all Form 4s, filed between Feb 21, 2025 and Mar 11, 2026. Those filings report 4 transactions, from Feb 19, 2025 to Mar 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Driscoll Michael Joseph's filings is in CANTON, MA.
Recent filings by Driscoll Michael Joseph
Other insiders filing for Organogenesis Holdings Inc. (ORGO)
- Grow Brian, Chief Commercial Officer
- Leibowitz Arthur S, Director
- Cavorsi Robert, Vice President, Strategy
- Montecalvo Antonio S., Vice President, Health Policy
- Gillheeney Gary S., President and CEO
- Bilbo Patrick, Chief Operating Officer